A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

Author： on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.5, 1996-05, pp. : 807-813

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite

The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy

By Carmichael James   Harris Adrian  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 123-128

Springer Publishing Company

Access to resources Recommend Favorite

A Double-blind Crossover Study Comparing Prophylactic Intravenous Granisetron Alone or in Combination with Dexamethasone as Antiemetic Treatment in Controlling Nausea and Vomiting Associated with Chemotherapy

By Kirchner V.   Aapro M.   Terrey J.-P.   Alberto P.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1605-1610

Elsevier

Access to resources Recommend Favorite

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

By Herrstedt J.   Sigsgaard TC   Nielsen HA   Handberg J.   Langer SW   Ottesen S.   Dombernowsky P.  

Supportive Care in Cancer, Vol. 15, Iss. 4, 2007-04 ,pp. : 417-426

Springer Publishing Company

Access to resources Recommend Favorite